J. Dawn Abbott, M.D., is the Director of the Interventional Cardiology Fellowship Training Program at Brown and an interventional cardiologist at Rhode Island Hospital. Her clinical research focuses on percutaneous coronary intervention and peripheral arterial disease. She is a Co-Investigator on the NIH-Sponsored MINT Trial, a grant that is funding a pilot trial to evaluate the role of transfusion therapy in patients with symptomatic coronary artery disease. She is the Site-Principal Investigator at Rhode Island Hospital for several NIH funded studies (Dynamic Registry of Percutaneous Coronary Intervention, PACE-MI, BARI 2D) as well as multicenter investigator initiated and industry funded trials. She has examined the importance of several factors such as stent selection (drug-eluting versus bare metal), gender, and antiplatelet therapy on outcomes in percutaneous intervention. Current actively enrolling trials include the SAFE-PCI trial examining radial versus femoral access for coronary intervention in women, the RIVER-PCI trial assessing the use of the antianginal drug ranolazine in patients with incomplete revascularization, and the renalguard study examining prevention of contrast induced nephropathy by forced diuresis.
| Bavishi C, Abbott JD. "Anticoagulation in ST-Elevation Myocardial Infarction." Interventional Cardiology Clinics, vol. 10, no. 3, 2021, pp. 307-316. |
| Jhand A, Atti V, Gwon Y, Dhawan R, Turagam MK, Mamas MA, Brilakis ES, Kumar A, Katta N, Chatzizisis Y, Parikh M, Abbott JD, Kirtane AJ, Bhatt DL, Velagapudi P. "Meta-Analysis of Transradial vs Transfemoral Access for Percutaneous Coronary Intervention in Patients With ST Elevation Myocardial Infarction." The American Journal of Cardiology, vol. 141, 2021, pp. 23-30. |
| Megaly M, Buda K, Saad M, Tawadros M, Elbadawi A, Basir M, Abbott JD, Rinfret S, Alaswad K, Brilakis ES. "Outcomes with drug-coated balloons vs. drug-eluting stents in small-vessel coronary artery disease." Cardiovascular Revascularization Medicine, 2021. |
| Yeh RW, Bachinsky W, Stoler R, Bateman C, Tremmel JA, Abbott JD, Dohad S, Batchelor W, Underwood P, Allocco DJ, Kirtane AJ. "Rationale and Design of a Randomized Study Comparing the Agent Drug Coated Balloon to Plain Old Balloon Angioplasty in Patients with In-Stent Restenosis." American Heart Journal, 2021. |
| Naidu SS, Abbott JD, Bagai J, Blankenship J, Garcia S, Iqbal SN, Kaul P, Khuddus MA, Kirkwood L, Manoukian SV, Patel MR, Skelding K, Slotwiner D, Swaminathan RV, Welt FG, Kolansky DM. "SCAI Expert Consensus Update on Best Practices in the Cardiac Catheterization Laboratory." Catheterization and Cardiovascular Interventions, 2021. |
| Ahmad K, Abbott JD. "Supersaturated oxygen therapy in acute anterior myocardial infarction: Going small is the next big thing." Catheterization and Cardiovascular Interventions, vol. 97, no. 6, 2021, pp. 1127-1128. |
| Garg R, Joe D, Abbott JD. "A Case of Acute Thrombotic Myocardial Infarction in Polyarteritis Nodosa." Rhode Island medical journal (2013), vol. 103, no. 7, 2020, pp. 65-67. |
| Lam MC, Naidu SS, Kolte D, Kennedy K, Feldman DN, Chu AF, Abbott JD, Gordon P, Aronow HD. "Cardiac implantable electronic device placement following alcohol septal ablation for hypertrophic cardiomyopathy in the United States." Journal of cardiovascular electrophysiology, vol. 31, no. 10, 2020, pp. 2712-2719. |
| Hamandi M, Saad M, Hasan R, Megaly M, Abbott JD, Dib C, Szerlip M, Potluri S, Lotfi A, Kiemeneij F, Al-Azizi KM. "Distal Versus Conventional Transradial Artery Access for Coronary Angiography and Intervention: A Meta-Analysis." Cardiovascular Revascularization Medicine, vol. 21, no. 10, 2020, pp. 1209-1213. |
| Apostolidou E, Kolte D, Kennedy KF, Beale CE, Abbott JD, Ehsan A, Gurm HS, Carson JL, Mamdani S, Aronow HD. "Institutional Red Blood Cell Transfusion Rates Are Correlated Following Endovascular and Surgical Cardiovascular Procedures: Evidence That Local Culture Influences Transfusion Decisions." Journal of the American Heart Association, vol. 9, no. 22, 2020, pp. e016232. |
| Bavishi C, Trivedi V, Sellke FW, Gordon PC, Abbott JD. "Myocardial Contractile Reserve and Mortality in Patients with Severe Aortic Stenosis with Impaired Left Ventricular Function Undergoing Transcatheter Aortic Valve Implantation." The American Journal of Cardiology, 2020. |
| Garg, Rimmy, Fu, Danni, McRee, Chad, Anderson, Kelsey, Kennedy, Kevin, Aronow, Herbert D., Tuohy, Christopher, Abbott, J. Dawn. "Outcomes of Transradial Approach to Percutaneous Coronary Intervention in End-Stage Renal Disease Patients on Dialysis." Cardiovascular Revascularization Medicine, vol. 21, no. 9, 2020, pp. 1131-1135. |
| Goldsweig AM, Lyden E, Aronow HD, Kolte D, Pavlides G, Barton D, Chatzizisis Y, Gumina RJ, Abbott JD. "Predictors of Contrast Volume in Transcatheter Aortic Valve Replacement." Cardiology, vol. 145, no. 9, 2020, pp. 608-610. |
| Altin SE, Castro-Dominguez YS, Kennedy KF, Orion KC, Lanksy AJ, Abbott JD, Aronow HD. "Predictors of Underutilization of Medical Therapy in Patients Undergoing Endovascular Revascularization for Peripheral Artery Disease." JACC: Cardiovascular Interventions, vol. 13, no. 24, 2020, pp. 2911-2918. |
| Abbott JD, Bavishi C. "Progressing toward lower high resource utilization in TAVR." Cardiovascular Revascularization Medicine, 2020. |
| Altin SE, Kim YG, Aronow HD, Armstrong EJ, Goldsweig AM, Dardik A, Lanksy AJ, Mena-Hurtado CI, Abbott JD. "Seasonal variation in U.S. hospitalizations for chronic limb-threatening ischemia." Catheterization and Cardiovascular Interventions, vol. 96, no. 7, 2020, pp. 1473-1480. |
| Amgai B, Chakraborty S, Bandyopadhyay D, Gupta M, Patel N, Hajra A, Dey AK, Koirala S, Ghosh RK, Aronow WS, Kolte D, Abbott JD. "Sex Differences in In-Hospital Outcomes of Transcatheter Aortic Valve Replacement." Current problems in cardiology, 2020, pp. 100694. |
| Elbadawi A, Elgendy IY, Saad M, Mahmoud K, Abbott JD, Jneid H, Bhatt DL. "The Reply." The American Journal of Medicine, vol. 133, no. 4, 2020, pp. e164-e165. |
| Louis DW, Kolte D, Kennedy K, Lima FV, Abbott JD, Shemin D, Mamdani S, Aronow HD. "Thirty-Day Readmission After Medical Versus Endovascular Therapy for Atherosclerotic Renal Artery Stenosis." The American Journal of Cardiology, vol. 125, no. 7, 2020, pp. 1115-1122. |
| Lima, Fabio V., Kolte, Dhaval, Kennedy, Kevin F., Wang, Lily J., Abbott, J. Dawn, Soukas, Peter A., Aronow, Herbert D. "Thirty-Day Readmissions After Carotid Artery Stenting Versus Endarterectomy: Analysis of the 2013-2014 Nationwide Readmissions Database." Circulation: Cardiovascular Interventions, vol. 13, no. 4, 2020, pp. e008508. |
| Lima FV, Kolte D, Rofeberg V, Molino J, Zhang Z, Elmariah S, Aronow HD, Abbott JD, Ben Assa E, Khera S, Gordon PC, Inglessis I, Palacios IF. "Thirty-day readmissions after transcatheter versus surgical mitral valve repair in high-risk patients with mitral regurgitation: Analysis of the 2014-2015 Nationwide readmissions databases." Catheterization and Cardiovascular Interventions, vol. 96, no. 3, 2020, pp. 664-674. |
| Chaudry H, Abbott JD. "Times up to demonstrate a difference is current DES platforms." Catheterization and Cardiovascular Interventions, vol. 96, no. 7, 2020, pp. 1407-1408. |
| Bandyopadhyay D, Chakraborty S, Amgai B, Patel N, Hajra A, Ghosh RK, Kolte D, Fonarow GC, Ramee SR, Lavie CJ, Abbott JD. "Urgent Balloon Aortic Valvuloplasty or Urgent TAVR in Patients With Severe Aortic Stenosis: A Propensity-Matched Analysis." JACC: Cardiovascular Interventions, vol. 13, no. 2, 2020, pp. 274-275. |
| Johnston AL, Vemulapalli S, Gosch KL, Aronow HD, Abbott JD, Patel MR, Smolderen KG, Shishebor M, Spertus JA, Jones WS. "Ankle-brachial index in patients with intermittent claudication is a poor indicator of patient-centered and clinician-based evaluations of functional status." Journal of vascular surgery, vol. 69, no. 3, 2019, pp. 906-912. |
| Abdelaziz, Hesham K., Saad, Marwan, Pothineni, Naga Venkata K., Megaly, Michael, Potluri, Rahul, Saleh, Mohammed, Kon, David Lai Chin, Roberts, David H., Bhatt, Deepak L., Aronow, Herbert D., Abbott, J. Dawn, Mehta, Jawahar L. "Aspirin for Primary Prevention of Cardiovascular Events." Journal of the American College of Cardiology, vol. 73, no. 23, 2019, pp. 2915-2929. |
| Bavishi C, Chugh Y, Kimura T, Natsuaki M, Kaiser C, Gordon P, Aronow HD, Abbott JD. "Biodegradable Polymer Drug-Eluting Stent versus Contemporary Durable Polymer Drug-Eluting Stents in Patients with Diabetes: A Meta-analysis of Randomized Controlled Trials." European heart journal. Quality of care & clinical outcomes, 2019. |
| Rymer JA, Kaltenbach LA, Kochar A, Hess CN, Gilchrist IC, Messenger JC, Harrington RA, Jolly SS, Jacobs AK, Abbott JD, Wojdyla DM, Krucoff MW, Rao SV. "Comparison of Rates of Bleeding and Vascular Complications Before, During, and After Trial Enrollment in the SAFE-PCI Trial for Women." Circulation: Cardiovascular Interventions, vol. 12, no. 5, 2019, pp. e007086. |
| Valle JA, Tamez H, Abbott JD, Moussa ID, Messenger JC, Waldo SW, Kennedy KF, Masoudi FA, Yeh RW. "Contemporary Use and Trends in Unprotected Left Main Coronary Artery Percutaneous Coronary Intervention in the United States: An Analysis of the National Cardiovascular Data Registry Research to Practice Initiative." JAMA Cardiology, vol. 4, no. 2, 2019, pp. 100-109. |
| Gupta T, Khera S, Kolte D, Goel K, Villablanca PA, Abbott JD, Fonarow GC, Rihal CS, Garcia MJ, Bhatt DL, Latib A, Weisz G. "Corrigendum to `Trends in Utilization of Surgical and Transcatheter Mitral Valve Repair in the United States☆' [The American Journal of Cardiology 123/7 (2019) 1187-1189]." The American Journal of Cardiology, vol. 124, no. 1, 2019, pp. 168. |
| Sardar P, Abbott JD, Kundu A, Aronow HD, Granada JF, Giri J. "Impact of Artificial Intelligence on Interventional Cardiology." JACC: Cardiovascular Interventions, vol. 12, no. 14, 2019, pp. 1293-1303. |
| Velagapudi P, Turagam MK, Kolte D, Khera S, Gupta T, Garg J, Abbott JD, George I, Khalique O, Vahl T, Nazif T, Lakkireddy D, Kodali S, Sommer R. "Intracardiac vs transesophageal echocardiography for percutaneous left atrial appendage occlusion: A meta-analysis." Journal of cardiovascular electrophysiology, vol. 30, no. 4, 2019, pp. 461-467. |
| Velagapudi P, Turagam M, Kolte D, Khera S, Hyder O, Gordon P, Aronow HD, Leopold J, Abbott JD. "Intramyocardial autologous CD34+ cell therapy for refractory angina: A meta-analysis of randomized controlled trials." Cardiovascular Revascularization Medicine, vol. 20, no. 3, 2019, pp. 215-219. |
| Elbadawi A, Elgendy IY, Ha LD, Mahmoud K, Lenka J, Olorunfemi O, Reyes A, Ogunbayo GO, Saad M, Abbott JD. "National Trends and Outcomes of Percutaneous Coronary Intervention in Patients ≥70 Years of Age With Acute Coronary Syndrome (from the National Inpatient Sample Database)." The American Journal of Cardiology, vol. 123, no. 1, 2019, pp. 25-32. |
| Abbott JD, Bavishi C. "Next-Generation Bioresorbable Vascular Scaffolds: When to Get Our Hopes Up?." JACC: Cardiovascular Interventions, vol. 12, no. 3, 2019, pp. 256-258. |
| Rymer JA, Mandawat A, Abbott JD, Cohen MG, Davies JE, Gilchrist IC, Jolly SS, Popma JJ, Al-Khalidi HR, Rao SV, Kong D, Krucoff M. "Opportunities for enhancing the care of older patients with ST-elevation myocardial infarction presenting for primary percutaneous coronary intervention: Rationale and design of the SAFE-STEMI for Seniors trial." American Heart Journal, vol. 218, 2019, pp. 84-91. |
| Goldsweig, Andrew M., Kennedy, Kevin F., Abbott, J. Dawn, Jones, W. Schuyler, Velagapudi, Poonam, Rutar, Frank J., Curtis, Jeptha C., Tsai, Thomas T., Aronow, Herbert D. "Patient Radiation Dosage During Lower Extremity Endovascular Intervention." JACC: Cardiovascular Interventions, vol. 12, no. 5, 2019, pp. 473-480. |
| Wu, Carolyn M., McKeon, John, Abbott, J. Dawn, Jiang, Lan, Wu, Wen-Chih. "Referral to Cardiac Rehabilitation and Outcomes for Patients With Takotsubo Cardiomyopathy." Journal of Cardiopulmonary Rehabilitation and Prevention, vol. 39, no. 3, 2019, pp. E8-E11. |
| Sardar P, Giri J, Jaff MR, Parikh SA, Kundu A, White CJ, Chatterjee S, Kennedy KF, Desai NR, Hyder ON, Mukherjee D, Shishehbor MH, Abbott JD, Aronow HD. "Strength of Evidence Underlying the American Heart Association/American College of Cardiology Guidelines on Endovascular and Surgical Treatment of Peripheral Vascular Disease." Circulation: Cardiovascular Interventions, vol. 12, no. 1, 2019, pp. e007244. |
| Elbadawi A, Elgendy IY, Naqvi SY, Mohamed AH, Ogunbayo GO, Omer MA, Mentias A, Saad M, Abbott JD, Jneid H, Bhatt DL. "Temporal Trends and Outcomes of Hospitalizations With Prinzmetal Angina: Perspectives From a National Database." The American Journal of Medicine, vol. 132, no. 9, 2019, pp. 1053-1061.e1. |
| Elbadawi A, Saad M, Elgendy IY, Barssoum K, Omer MA, Soliman A, Almahmoud MF, Ogunbayo GO, Mentias A, Gilani S, Jneid H, Aronow HD, Kleiman N, Abbott JD. "Temporal Trends and Outcomes of Transcatheter Versus Surgical Aortic Valve Replacement for Bicuspid Aortic Valve Stenosis." JACC: Cardiovascular Interventions, vol. 12, no. 18, 2019, pp. 1811-1822. |
| Gupta T, Kolte D, Khera S, Goel K, Villablanca PA, Kalra A, Abbott JD, Elmariah S, Fonarow GC, Rihal CS, Garcia MJ, Weisz G, Bhatt DL, Collaborators. "The changing landscape of aortic valve replacement in the USA." EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology, vol. 15, no. 11, 2019, pp. e968-e974. |
| Goldsweig AM, Tak HJ, Chen LW, Aronow HD, Shah B, Kolte DS, Velagapudi P, Desai N, Szerlip M, Abbott JD. "The Evolving Management of Aortic Valve Disease: 5-Year Trends in SAVR, TAVR, and Medical Therapy." The American Journal of Cardiology, 2019. |
| Lima FV, Kolte D, Louis DW, Kennedy KF, Abbott JD, Soukas PA, Hyder ON, Mamdani ST, Aronow HD. "Thirty-day readmission after endovascular or surgical revascularization for chronic mesenteric ischemia: Insights from the Nationwide Readmissions Database." Vascular Medicine, vol. 24, no. 3, 2019, pp. 216-223. |
| Kolte D, Beale C, Aronow HD, Kennedy KF, Apostolidou E, Sellke FW, Sharaf BL, Gordon PC, Abbott JD, Ehsan A. "Trends and outcomes of red blood cell transfusion in patients undergoing transcatheter aortic valve replacement in the United States." The Journal of Thoracic and Cardiovascular Surgery, 2019. |
| Gupta T, Khera S, Kolte D, Goel K, Villablanca PA, Abbott JD, Fonarow GC, Rihal CS, Garcia MJ, Bhatt DL, Latib A, Weisz G. "Trends in Utilization of Surgical and Transcatheter Mitral Valve Repair in the United States<sup>⋆</sup>." The American Journal of Cardiology, vol. 123, no. 7, 2019, pp. 1187-1189. |
| Faxon DP, Leopold JA, Abbott JD, McElhinney DB, Williams DO. "<i>Circulation: Cardiovascular Interventions</i>: The First 10 Years." Circulation: Cardiovascular Interventions, vol. 11, no. 6, 2018, pp. e006901. |
| Washam JB, Kaltenbach LA, Wojdyla DM, Patel MR, Klein AJ, Abbott JD, Rao SV. "Anticoagulant Use Among Patients With End-Stage Renal Disease Undergoing Percutaneous Coronary Intervention: An Analysis From the National Cardiovascular Data Registry." Circulation: Cardiovascular Interventions, vol. 11, no. 2, 2018, pp. e005628. |
| Noyes AM, Abbott JD, Gosch K, Smolderen K, Spertus JA, Hyder O, Soukas P, Shishehbor MH, Aronow HD. "Association between health status and sociodemographic, clinical and treatment disparities in the Patient-centered Outcomes Related to TReatment Practices in Peripheral Arterial Disease: Investigating Trajectories (PORTRAIT) registry." Vascular Medicine, vol. 23, no. 1, 2018, pp. 32-38. |
| Louis DW, Kennedy K, Lima FV, Pancholy SB, Abbott JD, Gordon P, Aronow HD. "Association Between Maximal Activated Clotting Time and Major Bleeding Complications During Transradial and Transfemoral Percutaneous Coronary Intervention." JACC: Cardiovascular Interventions, vol. 11, no. 11, 2018, pp. 1036-1045. |
| Berry NC, Kereiakes DJ, Yeh RW, Steg PG, Cutlip DE, Jacobs AK, Abbott JD, Hsieh WH, Massaro JM, Mauri L, DAPT Study Investigators. "Benefit and Risk of Prolonged DAPT After Coronary Stenting in Women." Circulation: Cardiovascular Interventions, vol. 11, no. 8, 2018, pp. e005308. |
| Tripathi A, Flaherty MP, Abbott JD, Fonarow GC, Khan AR, Saraswat A, Chahil H, Kolte D, Elmariah S, Hirsch GA, Mathew V, Kirtane AJ, Bhatt DL. "Comparison of Causes and Associated Costs of 30-Day Readmission of Transcatheter Implantation Versus Surgical Aortic Valve Replacement in the United States (A National Readmission Database Study)." The American Journal of Cardiology, vol. 122, no. 3, 2018, pp. 431-439. |
| Kolte, Dhaval, Goldsweig, Andrew, Kennedy, Kevin F., Abbott, J. Dawn, Gordon, Paul C., Sellke, Frank W., Ehsan, Afshin, Sodha, Neel, Sharaf, Barry L., Aronow, Herbert D. "Comparison of Incidence, Predictors, and Outcomes of Early Infective Endocarditis after Transcatheter Aortic Valve Implantation Versus Surgical Aortic Valve Replacement in the United States." The American Journal of Cardiology, vol. 122, no. 12, 2018, pp. 2112-2119. |
| Gupta T, Kolte D, Khera S, Agarwal N, Villablanca PA, Goel K, Patel K, Aronow WS, Wiley J, Bortnick AE, Aronow HD, Abbott JD, Pyo RT, Panza JA, Menegus MA, Rihal CS, Fonarow GC, Garcia MJ, Bhatt DL. "Contemporary Sex-Based Differences by Age in Presenting Characteristics, Use of an Early Invasive Strategy, and Inhospital Mortality in Patients With Non-ST-Segment-Elevation Myocardial Infarction in the United States." Circulation: Cardiovascular Interventions, vol. 11, no. 1, 2018, pp. e005735. |
| Schmidt T, Abbott JD. "Coronary Stents: History, Design, and Construction." Journal of Clinical Medicine, vol. 7, no. 6, 2018. |
| Echouffo-Tcheugui JB, Kolte D, Khera S, Aronow HD, Abbott JD, Bhatt DL, Fonarow GC. "Diabetes Mellitus and Cardiogenic Shock Complicating Acute Myocardial Infarction." The American Journal of Medicine, vol. 131, no. 7, 2018, pp. 778-786.e1. |
| Abbott JD. "Functional Significance of Epicardial Coronary Artery Disease in Women: One Piece of the Puzzle." JACC: Cardiovascular Interventions, vol. 11, no. 15, 2018, pp. 1464-1466. |
| Young LH, Viscoli CM, Schwartz GG, Inzucchi SE, Curtis JP, Gorman MJ, Furie KL, Conwit R, Spatz ES, Lovejoy A, Abbott JD, Jacoby DL, Kolansky DM, Ling FS, Pfau SE, Kernan WN, IRIS Investigators. "Heart Failure After Ischemic Stroke or Transient Ischemic Attack in Insulin-Resistant Patients Without Diabetes Mellitus Treated With Pioglitazone." Circulation, vol. 138, no. 12, 2018, pp. 1210-1220. |
| Velagapudi, Poonam, Turagam, Mohit, Kolte, Dhaval, Khera, Sahil, Parikh, Parag, Hyder, Omar, Aronow, Herbert, Abbott, J. Dawn. "Less than two versus greater than two hour invasive strategy in non-ST elevation myocardial infarction: a meta-analysis of randomized controlled trials." Expert Review of Cardiovascular Therapy, vol. 16, no. 1, 2018, pp. 67-72. |
| Khera S, Villablanca PA, Kolte D, Gupta T, Hasan Khan M, Velagapudi P, Kalra A, Kleiman N, Aronow HD, Abbott JD, Rosenfield K, Drachman DE, Bangalore S, Bhatt DL, Naidu SS. "Long-Term Outcomes of Drug-Eluting Stents Versus Bare-Metal Stents in End-Stage Renal Disease Patients on Dialysis: A Systematic Review and Meta-Analysis." Cardiology in review, vol. 26, no. 6, 2018, pp. 277-286. |
| Saad M, Nairooz R, Pothineni NVK, Almomani A, Kovelamudi S, Sardar P, Katz M, Abdel-Wahab M, Bangalore S, Kleiman NS, Block PC, Abbott JD. "Long-Term Outcomes With Transcatheter Aortic Valve Replacement in Women Compared With Men: Evidence From a Meta-Analysis." JACC: Cardiovascular Interventions, vol. 11, no. 1, 2018, pp. 24-35. |
| Abbott JD, Curtis JP. "More Than One Way to Close the Gender Gap." Journal of the American College of Cardiology, vol. 71, no. 19, 2018, pp. 2133-2135. |
| Mehanna E, Abbott JD, Bezerra HG. "Optimizing Percutaneous Coronary Intervention in Calcified Lesions: Insights From Optical Coherence Tomography of Atherectomy." Circulation: Cardiovascular Interventions, vol. 11, no. 5, 2018, pp. e006813. |
| Kolte D, Khera S, Vemulapalli S, Dai D, Heo S, Goldsweig AM, Aronow HD, Elmariah S, Inglessis I, Palacios IF, Thourani VH, Sharaf BL, Gordon PC, Abbott JD. "Outcomes Following Urgent/Emergent Transcatheter Aortic Valve Replacement: Insights From the STS/ACC TVT Registry." JACC: Cardiovascular Interventions, vol. 11, no. 12, 2018, pp. 1175-1185. |
| Smolderen KG, Gosch K, Patel M, Jones WS, Hirsch AT, Beltrame J, Fitridge R, Shishehbor MH, Denollet J, Vriens P, Heyligers J, Stone MEd N, Aronow H, Abbott JD, Labrosciano C, Tutein-Nolthenius R, A Spertus J. "PORTRAIT (Patient-Centered Outcomes Related to Treatment Practices in Peripheral Arterial Disease: Investigating Trajectories): Overview of Design and Rationale of an International Prospective Peripheral Arterial Disease Study." Circulation: Cardiovascular Quality and Outcomes, vol. 11, no. 2, 2018, pp. e003860. |
| Sardar P, Kundu A, Poppas A, Abbott JD. "Representation of Women in American College of Cardiology/American Heart Association Guideline Writing Committees." Journal of the American College of Cardiology, vol. 72, no. 4, 2018, pp. 464-466. |
| Velagapudi, Poonam, Kolte, Dhaval, Ather, Kashif, Khera, Sahil, Gupta, Tanush, Gordon, Paul C., Aronow, Herbert D., Kirtane, Ajay J., Abbott, J. Dawn. "Temporal Trends and Factors Associated With Prolonged Length of Stay in Patients With ST-Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention." The American Journal of Cardiology, vol. 122, no. 2, 2018, pp. 185-191. |
| Bavishi C, Kolte D, Gordon PC, Abbott JD. "Transcatheter aortic valve replacement in patients with severe aortic stenosis and heart failure." Heart failure reviews, vol. 23, no. 6, 2018, pp. 821-829. |
| Gupta T, Khera S, Kolte D, Goel K, Kalra A, Villablanca PA, Aronow HD, Abbott JD, Fonarow GC, Taub CC, Kleiman NS, Weisz G, Inglessis I, Elmariah S, Rihal CS, Garcia MJ, Bhatt DL. "Transcatheter Versus Surgical Aortic Valve Replacement in Patients With Prior Coronary Artery Bypass Grafting: Trends in Utilization and Propensity-Matched Analysis of In-Hospital Outcomes." Circulation: Cardiovascular Interventions, vol. 11, no. 4, 2018, pp. e006179. |
| Morrissey PJ, Murphy KR, Daley JM, Schofield L, Turan NN, Arunachalam K, Abbott JD, Koren G. "A novel method of standardized myocardial infarction in aged rabbits." AJP: Heart and Circulatory Physiology, vol. 312, no. 5, 2017, pp. ajpheart.00582.2016. |
| Khera, Sahil, Kolte, Dhaval, Gupta, Tanush, Goldsweig, Andrew, Velagapudi, Poonam, Kalra, Ankur, Tang, Gilbert H. L., Aronow, Wilbert S., Fonarow, Gregg C., Bhatt, Deepak L., Aronow, Herbert D., Kleiman, Neal S., Reardon, Michael, Gordon, Paul C., Sharaf, Barry, Abbott, J. Dawn. "Association Between Hospital Volume and 30-Day Readmissions Following Transcatheter Aortic Valve Replacement." JAMA Cardiology, vol. 2, no. 7, 2017, pp. 732-741. |
| Gupta T, Goel K, Kolte D, Khera S, Villablanca PA, Aronow WS, Bortnick AE, Slovut DP, Taub CC, Kizer JR, Pyo RT, Abbott JD, Fonarow GC, Rihal CS, Garcia MJ, Bhatt DL. "Association of Chronic Kidney Disease With In-Hospital Outcomes of Transcatheter Aortic Valve Replacement." JACC: Cardiovascular Interventions, vol. 10, no. 20, 2017, pp. 2050-2060. |
| Saad M, Nairooz R, Rashed A, Abdelaziz HK, Mentias A, Abbott JD. "Bivalirudin versus heparin in women undergoing percutaneous coronary intervention: A systematic review and meta-analysis of randomized clinical trials." Cardiovascular Revascularization Medicine, vol. 18, no. 6, 2017, pp. 418-424. |
| Young LH, Viscoli CM, Curtis JP, Inzucchi SE, Schwartz GG, Lovejoy AM, Furie KL, Gorman MJ, Conwit R, Abbott JD, Jacoby DL, Kolansky DM, Pfau SE, Ling FS, Kernan WN, IRIS Investigators. "Cardiac Outcomes After Ischemic Stroke or Transient Ischemic Attack: Effects of Pioglitazone in Patients With Insulin Resistance Without Diabetes Mellitus." Circulation, vol. 135, no. 20, 2017, pp. 1882-1893. |
| Kolte D, Sardar P, Khera S, Zeymer U, Thiele H, Hochadel M, Radovanovic D, Erne P, Hambraeus K, James S, Claessen BE, Henriques JPS, Mylotte D, Garot P, Aronow WS, Owan T, Jain D, Panza JA, Frishman WH, Fonarow GC, Bhatt DL, Aronow HD, Abbott JD. "Culprit Vessel-Only Versus Multivessel Percutaneous Coronary Intervention in Patients With Cardiogenic Shock Complicating ST-Segment-Elevation Myocardial Infarction: A Collaborative Meta-Analysis." Circulation: Cardiovascular Interventions, vol. 10, no. 11, 2017. |
| Lima, Fabio V., Kolte, Dhaval, Kennedy, Kevin F., Louis, David W., Abbott, J. Dawn, Soukas, Peter A., Hyder, Omar N., Mamdani, Shafiq T., Aronow, Herbert D. "Endovascular Versus Surgical Revascularization for Chronic Mesenteric Ischemia." JACC: Cardiovascular Interventions, vol. 10, no. 23, 2017, pp. 2440-2447. |
| Abbott JD. "How and When to Evaluate Nonculprit Lesions in ST-Segment Elevation Myocardial Infarction." JACC: Cardiovascular Interventions, vol. 10, no. 24, 2017, pp. 2536-2538. |
| Nairooz R, Saad M, Elgendy IY, Mahmoud AN, Habash F, Sardar P, Anderson D, Shavelle DM, Abbott JD. "Long-term outcomes of provisional stenting compared with a two-stent strategy for bifurcation lesions: a meta-analysis of randomised trials." Heart (British Cardiac Society), vol. 103, no. 18, 2017, pp. 1427-1434. |
| Sardar P, Giri J, Elmariah S, Chatterjee S, Kolte D, Kundu A, Nairooz R, Aronow WS, Owan T, Mukherjee D, Feldman DN, Abbott JD. "Meta-Analysis of Drug-Eluting Stents Versus Coronary Artery Bypass Grafting in Unprotected Left Main Coronary Narrowing." The American Journal of Cardiology, vol. 119, no. 11, 2017, pp. 1746-1752. |
| Kolte D, Aronow HD, Abbott JD. "Noninferiority Trials in Interventional Cardiology." Circulation: Cardiovascular Interventions, vol. 10, no. 8, 2017. |
| Goldsweig, Andrew M., Abbott, J. Dawn, Aronow, Herbert D. "Physician and Patient Radiation Exposure During Endovascular Procedures." Current Treatment Options in Cardiovascular Medicine, vol. 19, no. 2, 2017, pp. 10. |
| Goldsweig AM, Kennedy KF, Kolte D, Abbott JD, Gordon PC, Sharaf BL, Sellke FW, Ehsan A, Sodha NR, Rutar F, Aronow HD. "Predictors of patient radiation exposure during transcatheter aortic valve replacement." Catheterization and Cardiovascular Interventions, vol. 92, no. 4, 2017, pp. 768-774. |
| Gupta T, Kalra A, Kolte D, Khera S, Villablanca PA, Goel K, Bortnick AE, Aronow WS, Panza JA, Kleiman NS, Abbott JD, Slovut DP, Taub CC, Fonarow GC, Reardon MJ, Rihal CS, Garcia MJ, Bhatt DL. "Regional Variation in Utilization, In-hospital Mortality, and Health-Care Resource Use of Transcatheter Aortic Valve Implantation in the United States." The American Journal of Cardiology, vol. 120, no. 10, 2017, pp. 1869-1876. |
| Roumia M, Aronow HD, Soukas P, Gosch K, Smolderen KG, Spertus JA, Abbott JD. "Sex differences in disease-specific health status measures in patients with symptomatic peripheral artery disease: Data from the PORTRAIT study." Vascular Medicine, vol. 22, no. 2, 2017, pp. 103-109. |
| Abbott JD. "The Past, Present, and Future of Dual-Antiplatelet Therapy Duration in Percutaneous Coronary Intervention." Annals of Internal Medicine, vol. 167, no. 1, 2017, pp. 57-58. |
| Tripathi A, Abbott JD, Fonarow GC, Khan AR, Barry NG 4th, Ikram S, Coram R, Mathew V, Kirtane AJ, Nallamothu BK, Hirsch GA, Bhatt DL. "Thirty-Day Readmission Rate and Costs After Percutaneous Coronary Intervention in the United States: A National Readmission Database Analysis." Circulation: Cardiovascular Interventions, vol. 10, no. 12, 2017. |
| Kolte D, Kennedy KF, Shishehbor MH, Abbott JD, Khera S, Soukas P, Mamdani ST, Hyder ON, Drachman DE, Aronow HD. "Thirty-Day Readmissions After Endovascular or Surgical Therapy for Critical Limb Ischemia: Analysis of the 2013 to 2014 Nationwide Readmissions Databases." Circulation, vol. 136, no. 2, 2017, pp. 167-176. |
| Kolte D, Khera S, Sardar MR, Gheewala N, Gupta T, Chatterjee S, Goldsweig A, Aronow WS, Fonarow GC, Bhatt DL, Greenbaum AB, Gordon PC, Sharaf B, Abbott JD. "Thirty-Day Readmissions After Transcatheter Aortic Valve Replacement in the United States: Insights From the Nationwide Readmissions Database." Circulation: Cardiovascular Interventions, vol. 10, no. 1, 2017. |
| Sardar MR, Goldsweig AM, Abbott JD, Sharaf BL, Gordon PC, Ehsan A, Aronow HD. "Vascular complications associated with transcatheter aortic valve replacement." Vascular Medicine, vol. 22, no. 3, 2017, pp. 234-244. |
| Mehanna E, Abbott JD. "Vulnerable plaques, more than meets the i." Catheterization and Cardiovascular Interventions, vol. 90, no. 7, 2017, pp. 1115-1116. |
| Brown BJ, Abbott JD. "A helping hand: GuideLiner use to facilitate stent delivery." Catheterization and Cardiovascular Interventions, vol. 88, no. 7, 2016, pp. 1065-1066. |
| Kolte D, Spence N, Puthawala M, Hyder O, Tuohy CP, Davidson CB, Sheldon MW, Laskey WK, Abbott JD. "Association of radial versus femoral access with contrast-induced acute kidney injury in patients undergoing primary percutaneous coronary intervention for ST-elevation myocardial infarction." Cardiovascular Revascularization Medicine, vol. 17, no. 8, 2016, pp. 546-551. |
| Parikh, Valay, Agnihotri, Kanishk, Kadavath, Sabeeda, Patel, Nileshkumar J., Abbott, J. Dawn. "Clinical Application of Fractional Flow Reserve–Guided Percutaneous Coronary Intervention for Stable Coronary Artery Disease." Current Cardiology Reports, vol. 18, no. 4, 2016. |
| Spence N, Abbott JD. "Coronary Revascularization in Cardiogenic Shock." Current treatment options in cardiovascular medicine, vol. 18, no. 1, 2016, pp. 1. |
| Velagapudi P, Abbott JD. "Defining small vessels and bioresorbable vascular scaffold outcomes." Catheterization and Cardiovascular Interventions, vol. 88, no. 3, 2016, pp. 388-9. |
| Motivala AA, Parikh V, Roe M, Dai D, Abbott JD, Prasad A, Mukherjee D. "Predictors, Trends, and Outcomes (Among Older Patients ≥65 Years of Age) Associated With Beta-Blocker Use in Patients With Stable Angina Undergoing Elective Percutaneous Coronary Intervention: Insights From the NCDR Registry." JACC: Cardiovascular Interventions, vol. 9, no. 16, 2016, pp. 1639-48. |
| Sardar P, Chatterjee S, Kundu A, Samady H, Owan T, Giri J, Nairooz R, Selzman CH, Heusch G, Gersh BJ, Abbott JD, Mukherjee D, Fang JC. "Remote ischemic preconditioning in patients undergoing cardiovascular surgery: Evidence from a meta-analysis of randomized controlled trials." International Journal of Cardiology, vol. 221, 2016, pp. 34-41. |
| Motivala AA, Parikh V, Roe M, Dai D, Abbott JD, Prasad A, Mukherjee D. "Reply: Effect of Pre-Procedural β-Blocker in Patients Undergoing Percutaneous Coronary Intervention." JACC: Cardiovascular Interventions, vol. 9, no. 23, 2016, pp. 2459-2460. |
| Kolte, Dhaval, Dawn Abbott, J. "Saphenous vein graft lesions: Are second-generation drug-eluting stents better?." Catheterization and Cardiovascular Interventions, vol. 87, no. 1, 2016, pp. 41-42. |
| Epps KC, Holper EM, Selzer F, Vlachos HA, Gualano SK, Abbott JD, Jacobs AK, Marroquin OC, Naidu SS, Groeneveld PW, Wilensky RL. "Sex Differences in Outcomes Following Percutaneous Coronary Intervention According to Age." Circulation: Cardiovascular Quality and Outcomes, vol. 9, no. 2 Suppl 1, 2016, pp. S16-25. |
| Abbott JD. "The Importance of Subgroup Analysis in Drug-Eluting Stent Trials." JACC: Cardiovascular Interventions, vol. 9, no. 1, 2016, pp. 39-41. |
| Kolte D, Khera S, Dabhadkar KC, Agarwal S, Aronow WS, Timmermans R, Jain D, Cooper HA, Frishman WH, Menon V, Bhatt DL, Abbott JD, Fonarow GC, Panza JA. "Trends in Coronary Angiography, Revascularization, and Outcomes of Cardiogenic Shock Complicating Non-ST-Elevation Myocardial Infarction." The American Journal of Cardiology, vol. 117, no. 1, 2016, pp. 1-9. |
| Abbott JD. "Women in Interventional Cardiology: Small Numbers, Big Impact." Circulation: Cardiovascular Interventions, vol. 9, no. 8, 2016. |
| Driesman, Adam, Hyder, Omar, Lang, Christopher, Stockwell, Phillip, Poppas, Athena, Dawn Abbott, J. "Incidence and Predictors of Left Ventricular Thrombus After Primary Percutaneous Coronary Intervention for Anterior ST-Segment Elevation Myocardial Infarction." Clinical Cardiology, vol. 38, no. 10, 2015, pp. 590-7. |
| Abbott JD. "Measuring the Effectiveness of Percutaneous Coronary Intervention." Circulation: Cardiovascular Interventions, vol. 8, no. 8, 2015, pp. e003024. |
| Kakkar AM, Abbott JD. "Percutaneous versus surgical management of lower extremity peripheral artery disease." Current Atherosclerosis Reports, vol. 17, no. 2, 2015, pp. 479. |
| Solomon R, Gordon P, Manoukian SV, Abbott JD, Kereiakes DJ, Jeremias A, Kim M, Dauerman HL, BOSS Trial Investigators. "Randomized Trial of Bicarbonate or Saline Study for the Prevention of Contrast-Induced Nephropathy in Patients with CKD." Clinical journal of the American Society of Nephrology : CJASN, vol. 10, no. 9, 2015, pp. 1519-24. |
| Srour, John Fani, Abbott, J. Dawn. "Small vessels and long lesions." Catheterization and Cardiovascular Interventions, vol. 85, no. 2, 2015, pp. 216-217. |
| Abbott JD. "Controlling radiation exposure in interventional cardiology." Circulation: Cardiovascular Interventions, vol. 7, no. 4, 2014, pp. 425-8. |
| Pradhan A, Abbott JD. "Improvements in transfemoral catheterization access techniques." Cardiology, vol. 129, no. 1, 2014, pp. 36-8. |
| Parikh SV, Luna M, Selzer F, Marroquin OC, Mulukutla SR, Abbott JD, Holper EM. "Outcomes of small coronary artery stenting with bare-metal stents versus drug-eluting stents: results from the NHLBI Dynamic Registry." Catheterization and Cardiovascular Interventions, vol. 83, no. 2, 2014, pp. 192-200. |
| Stergiopoulos K, Boden WE, Hartigan P, Möbius-Winkler S, Hambrecht R, Hueb W, Hardison RM, Abbott JD, Brown DL. "Percutaneous coronary intervention outcomes in patients with stable obstructive coronary artery disease and myocardial ischemia: a collaborative meta-analysis of contemporary randomized clinical trials." JAMA Internal Medicine, vol. 174, no. 2, 2014, pp. 232-40. |
| Althouse AD, Abbott JD, Forker AD, Bertolet M, Barinas-Mitchell E, Thurston RC, Mulukutla S, Aboyans V, Brooks MM, BARI 2D Study Group. "Risk factors for incident peripheral arterial disease in type 2 diabetes: results from the Bypass Angioplasty Revascularization Investigation in type 2 Diabetes (BARI 2D) Trial." Diabetes Care, vol. 37, no. 5, 2014, pp. 1346-52. |
| Srour JF, Abbott JD. "Routine postdilation of drug-eluting stents: worth the gain." Catheterization and Cardiovascular Interventions, vol. 83, no. 6, 2014, pp. 905-6. |
| Abbott JD. "The pace of transradial procedural learning." Circulation, vol. 129, no. 22, 2014, pp. 2250-2. |
| Young K, Earl T, Selzer F, Marroquin OC, Mulukutla SR, Cohen HA, Williams DO, Jacobs A, Kelsey SF, Abbott JD. "Trends in major entry site complications from percutaneous coronary intervention (from the Dynamic Registry)." The American Journal of Cardiology, vol. 113, no. 4, 2014, pp. 626-30. |
| Mulukutla SR, Marroquin OC, Vlachos HA, Selzer F, Toma C, Kip KE, Abbott JD, Holper E, Lee JS, Khandhar S, Kutcher M, Kelsey S, Smith C, Faxon D, Williams DO. "Benefit of long-term dual anti-platelet therapy in patients treated with drug-eluting stents: from the NHLBI dynamic registry." The American Journal of Cardiology, vol. 111, no. 4, 2013, pp. 486-92. |
| Abbott JD. "Diffusion of innovations and adoption of transradial intervention." Circulation: Cardiovascular Interventions, vol. 6, no. 3, 2013, pp. 199-200. |
| Earl TJ, Abbott JD. "Direct stenting: soft endpoints are enough." Catheterization and Cardiovascular Interventions, vol. 81, no. 6, 2013, pp. 957-8. |
| Abbott JD, Madiraju S. "Drug eluting stent neointimal regression: a welcomed change." Catheterization and Cardiovascular Interventions, vol. 81, no. 2, 2013, pp. 283-4. |
| Althouse AD, Abbott JD, Sutton-Tyrrell K, Forker AD, Lombardero MS, Buitrón LV, Pena-Sing I, Tardif JC, Brooks MM, BARI 2D Study Group. "Favorable effects of insulin sensitizers pertinent to peripheral arterial disease in type 2 diabetes: results from the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) trial." Diabetes Care, vol. 36, no. 10, 2013, pp. 3269-75. |
| Carson JL, Brooks MM, Abbott JD, Chaitman B, Kelsey SF, Triulzi DJ, Srinivas V, Menegus MA, Marroquin OC, Rao SV, Noveck H, Passano E, Hardison RM, Smitherman T, Vagaonescu T, Wimmer NJ, Williams DO. "Liberal versus restrictive transfusion thresholds for patients with symptomatic coronary artery disease." American Heart Journal, vol. 165, no. 6, 2013, pp. 964-971.e1. |
| Abbott JD. "Opportunity for improvement: use of intravascular ultrasound in stent thrombosis." Catheterization and Cardiovascular Interventions, vol. 81, no. 5, 2013, pp. 791-2. |
| Carson JL, Brooks MM, Abbott JD, Kelsey SF, Triulzi DJ, Menegus MA, Marroquin OC, Rao SV, Smitherman T, Vagaonescu T, Wimmer NJ, Williams DO. "Response to Dr Sandar et al." American Heart Journal, vol. 166, no. 4, 2013, pp. e27-8. |
| Abbott JD, Lombardero MS, Barsness GW, Pena-Sing I, Buitrón LV, Singh P, Woodhead G, Tardif JC, Kelsey SF. "Ankle-brachial index and cardiovascular outcomes in the Bypass Angioplasty Revascularization Investigation 2 Diabetes trial." American Heart Journal, vol. 164, no. 4, 2012, pp. 585-590.e4. |
| Truesdell AG, Abbott JD. "Bioresorbable polymers: a temporary solution?." Catheterization and Cardiovascular Interventions, vol. 80, no. 5, 2012, pp. 797-8. |
| Al Muradi H, Mehra A, Okolo J, Vlachos H, Selzer F, Marroquin OC, Skelding K, Holper EM, Williams DO, Abbott JD. "Clinical presentation and predictors of target vessel revascularization after drug-eluting stent implantation." Cardiovascular Revascularization Medicine, vol. 13, no. 6, 2012, pp. 311-5. |
| Vasaiwala S, Vlachos H, Selzer F, Marroquin O, Mulukutla S, Abbott JD, Williams DO. "Comparison of bare-metal stents and drug-eluting stents in coronary ostial lesions (from the National Heart, Lung, and Blood Institute Dynamic Registry)." The American Journal of Cardiology, vol. 110, no. 8, 2012, pp. 1113-8. |
| Abbott JD, Earl T, Vlachos HE, Selzer F, Vaidya KA, Romero A, Kip KE, Williams DO. "Direct stenting compared to balloon predilation in drug-eluting stents: one-year outcomes from the DEScover Registry." Catheterization and Cardiovascular Interventions, vol. 79, no. 1, 2012, pp. 84-9. |
| Abbott JD. "Lessons learned from recent randomized clinical trials for intermittent claudication." Circulation: Cardiovascular Interventions, vol. 5, no. 2, 2012, pp. 139-41. |
| Abbott JD. "More than addition: the use of fractional flow reserve in serial stenoses." JACC: Cardiovascular Interventions, vol. 5, no. 10, 2012, pp. 1019-20. |
| Leitner J, Vlachos HA, Selzer F, Jamal SM, Kip KE, Williams DO, Abbott JD. "Outcomes of drug-eluting stents for protected left main coronary artery disease (from the Multicenter, United States DEScover registry)." The American Journal of Cardiology, vol. 109, no. 4, 2012, pp. 466-70. |
| Spence N, Muratori J, Reinert SE, Sharaf BL, Abbott JD. "Sex differences in door to electrocardiogram and balloon times in patients with ST segment elevation myocardial infarction." Medicine and health, Rhode Island, vol. 95, no. 11, 2012, pp. 340-1. |
| Fernandez AB, Leitner J, Okolo J, Atalay MK, Goldstein L, Abbott JD. "Value of cardiovascular magnetic resonance in suspected cardiac amyloidosis." Journal of cardiovascular medicine (Hagerstown, Md.), vol. 13, no. 9, 2012, pp. 590-2. |
| Abbott JD, Obeidou B. "Bifurcation stenting with a provisional T strategy: drug eluting stent type does matter." Catheterization and Cardiovascular Interventions, vol. 78, no. 7, 2011, pp. 1093-4. |
| Abbott JD, Shah S. "Optimizing outcomes with a pharmacoinvasive strategy: is there a role for glycoprotein IIb/IIIa receptor antagonists?." Catheterization and Cardiovascular Interventions, vol. 78, no. 3, 2011, pp. 385-6. |
| Parikh SV, Saya S, Divanji P, Banerjee S, Selzer F, Abbott JD, Naidu SS, Wilensky RL, Faxon DP, Jacobs AK, Holper EM. "Risk of death and myocardial infarction in patients with peripheral arterial disease undergoing percutaneous coronary intervention (from the National Heart, Lung and Blood Institute Dynamic Registry)." The American Journal of Cardiology, vol. 107, no. 7, 2011, pp. 959-64. |
| Holper EM, Abbott JD, Mulukutla S, Vlachos H, Selzer F, McGuire D, Faxon DP, Laskey W, Srinivas VS, Marroquin OC, Jacobs AK. "Temporal changes in the outcomes of patients with diabetes mellitus undergoing percutaneous coronary intervention in the National Heart, Lung, and Blood Institute dynamic registry." American Heart Journal, vol. 161, no. 2, 2011, pp. 397-403.e1. |
| Singh PP, Abbott JD, Lombardero MS, Sutton-Tyrrell K, Woodhead G, Venkitachalam L, Tsapatsaris NP, Piemonte TC, Lago RM, Rutter MK, Nesto RW, Bypass Angioplasty Revascularization Investigation 2 Diabetes Study Group. "The prevalence and predictors of an abnormal ankle-brachial index in the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) trial." Diabetes Care, vol. 34, no. 2, 2011, pp. 464-7. |
| Bergman BR, Okolo J, Atalay MK, Abbott JD. "Utility of noninvasive imaging in suspected saphenous vein graft aneurysm thrombosis." Circulation: Cardiovascular Interventions, vol. 4, no. 5, 2011, pp. e36-7. |
| Baldwin, Drew E., Abbott, J. Dawn, Trost, Jeffrey C., Vlachos, Helen A., Selzer, Faith, Glaser, Ruchira, Wilensky, Robert L., Slater, James N., Doucet, Serge, Naidu, Srihari S., Aronow, Herbert D., Williams, David O. "Comparison of Drug-Eluting and Bare Metal Stents for Saphenous Vein Graft Lesions (from the National Heart, Lung, and Blood Institute Dynamic Registry)." The American Journal of Cardiology, vol. 106, no. 7, 2010, pp. 946-951. |
| Grogan M, Jenkins M, Sansing VV, MacGregor J, Brooks MM, Julien-Williams P, Amendola A, Abbott JD, BARI 2D Study Group. "Health insurance status and control of diabetes and coronary artery disease risk factors on enrollment into the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) trial." The Diabetes Educator, vol. 36, no. 5, 2010, pp. 774-83. |
| Wolf WM, Vlachos HA, Marroquin OC, Lee JS, Smith C, Anderson WD, Schindler JT, Holper EM, Abbott JD, Williams DO, Laskey WK, Kip KE, Kelsey SF, Mulukutla SR. "Paclitaxel-eluting versus sirolimus-eluting stents in diabetes mellitus: a report from the National Heart, Lung, and Blood Institute Dynamic Registry." Circulation: Cardiovascular Interventions, vol. 3, no. 1, 2010, pp. 42-9. |
| Abbott JD. "Pharmacoinvasive strategy for ST-segment elevation myocardial infarction: wading through the treatment options." Circulation: Cardiovascular Interventions, vol. 3, no. 4, 2010, pp. 294-6. |
| Williams DO, Abbott JD. "Diabetes mellitus does not unsweeten left main intervention." JACC: Cardiovascular Interventions, vol. 2, no. 10, 2009, pp. 964-6. |
| Kim LJ, King SB 3rd, Kent K, Brooks MM, Kip KE, Abbott JD, Jacobs AK, Rihal C, Hueb WA, Alderman E, Sing IR, Attubato MJ, Feit F, BARI 2D (Bypass Angioplasty Revascularization Investigation Type 2 Diabetes) Study Group. "Factors related to the selection of surgical versus percutaneous revascularization in diabetic patients with multivessel coronary artery disease in the BARI 2D (Bypass Angioplasty Revascularization Investigation in Type 2 Diabetes) trial." JACC: Cardiovascular Interventions, vol. 2, no. 5, 2009, pp. 384-92. |
| Kirchner RM, Abbott JD. "Update on the everolimus-eluting coronary stent system: results and implications from the SPIRIT clinical trial program." Vascular health and risk management, vol. 5, 2009, pp. 1089-97. |
| Marroquin OC, Selzer F, Mulukutla SR, Williams DO, Vlachos HA, Wilensky RL, Tanguay JF, Holper EM, Abbott JD, Lee JS, Smith C, Anderson WD, Kelsey SF, Kip KE. "A comparison of bare-metal and drug-eluting stents for off-label indications." New England Journal of Medicine, vol. 358, no. 4, 2008, pp. 342-52. |
| Mulukutla SR, Vlachos HA, Marroquin OC, Selzer F, Holper EM, Abbott JD, Laskey WK, Williams DO, Smith C, Anderson WD, Lee JS, Srinivas V, Kelsey SF, Kip KE. "Impact of drug-eluting stents among insulin-treated diabetic patients: a report from the National Heart, Lung, and Blood Institute Dynamic Registry." JACC: Cardiovascular Interventions, vol. 1, no. 2, 2008, pp. 139-47. |
| Shahabi S, Smith NA, Chanana C, Abbott JD, Copel J, Setaro JF. "Pregnancy-associated myocardial infarction: a report of two cases and review of the literature." Upsala journal of medical sciences, vol. 113, no. 3, 2008, pp. 325-30. |
| Abbott JD. "Revealing the silver and red lining in drug-eluting stents with angioscopy." Circulation: Cardiovascular Interventions, vol. 1, no. 1, 2008, pp. 7-9. |
| Williams DO, Abbott JD. "What to do with patients receiving long-term clopidogrel: reload or relax?." Circulation, vol. 118, no. 12, 2008, pp. 1219-22. |
| Abbott JD, Ahmed HN, Vlachos HA, Selzer F, Williams DO. "Comparison of outcome in patients with ST-elevation versus non-ST-elevation acute myocardial infarction treated with percutaneous coronary intervention (from the National Heart, Lung, and Blood Institute Dynamic Registry)." The American Journal of Cardiology, vol. 100, no. 2, 2007, pp. 190-5. |
| Williams DO, Abbott JD. "Et tu, bare metal stent?." Circulation, vol. 116, no. 21, 2007, pp. 2363-5. |
| Abbott JD, Vlachos HA, Selzer F, Sharaf BL, Holper E, Glaser R, Jacobs AK, Williams DO, National Heart, Lung, and Blood Institute Dynamic Registry. "Gender-based outcomes in percutaneous coronary intervention with drug-eluting stents (from the National Heart, Lung, and Blood Institute Dynamic Registry)." The American Journal of Cardiology, vol. 99, no. 5, 2007, pp. 626-31. |
| Abbott JD, Williams DO. "Lessons learned in the drug-eluting stent era." The American heart hospital journal, vol. 5, no. 3, 2007, pp. 169-72. |
| Abbott JD, Voss MR, Nakamura M, Cohen HA, Selzer F, Kip KE, Vlachos HA, Wilensky RL, Williams DO. "Unrestricted use of drug-eluting stents compared with bare-metal stents in routine clinical practice: findings from the National Heart, Lung, and Blood Institute Dynamic Registry." Journal of the American College of Cardiology, vol. 50, no. 21, 2007, pp. 2029-36. |
| Glaser R, Selzer F, Jacobs AK, Laskey WK, Kelsey SF, Holper EM, Cohen HA, Abbott JD, Wilensky RL. "Effect of gender on prognosis following percutaneous coronary intervention for stable angina pectoris and acute coronary syndromes." The American Journal of Cardiology, vol. 98, no. 11, 2006, pp. 1446-50. |
| Freeman AM, Abbott JD, Jacobs AK, Vlachos HA, Selzer F, Laskey WK, Detre KM, Williams DO. "Marked improvements in outcomes of contemporary percutaneous coronary intervention in patients with diabetes mellitus." Journal of interventional cardiology, vol. 19, no. 6, 2006, pp. 475-82. |
| Williams DO, Abbott JD, Kip KE, DEScover Investigators. "Outcomes of 6906 patients undergoing percutaneous coronary intervention in the era of drug-eluting stents: report of the DEScover Registry." Circulation, vol. 114, no. 20, 2006, pp. 2154-62. |
| Abbott JD, Kip KE, Vlachos HA, Sawhney N, Srinivas VS, Jacobs AK, Holmes DR, Williams DO. "Recent trends in the percutaneous treatment of chronic total coronary occlusions." The American Journal of Cardiology, vol. 97, no. 12, 2006, pp. 1691-6. |
| Williams DO, Abbott JD. "Bifurcation intervention: is it crush time yet?." Journal of the American College of Cardiology, vol. 46, no. 4, 2005, pp. 621-4. |
| Abbott JD, Choi EJ, Selzer F, Srinivas VS, Williams DO, National Heart, Lung, and Blood Institute Dynamic Registry. "Impact of coronary collaterals on outcome following percutaneous coronary intervention (from the National Heart, Lung, and Blood Institute Dynamic Registry)." The American Journal of Cardiology, vol. 96, no. 5, 2005, pp. 676-80. |
| Abbott JD, Huang Y, Liu D, Hickey R, Krause DS, Giordano FJ. "Stromal cell-derived factor-1alpha plays a critical role in stem cell recruitment to the heart after myocardial infarction but is not sufficient to induce homing in the absence of injury." Circulation, vol. 110, no. 21, 2004, pp. 3300-5. |
| Abbott JD, Curtis JP, Murad K, Kramer HM, Remetz MS, Setaro JF, Brennan JJ. "Spontaneous coronary artery dissection in a woman receiving 5-fluorouracil--a case report." Angiology, vol. 54, no. 6, 2003, pp. 721-4. |
American College of Cardiology Foundation (ACCF) Career Development Award in Acute Coronary Syndromes (07/05-06/06)
The Rhode Island Foundation: Medical Research Grant Award (2/07-1/08)
1RC2HL101458-01 NIH/NHLBI, Carson (PI), 2009-2011. Application Title: Transfusion Trigger Trial in Coronary Artery Disease: A Pilot Study. Project Period: 9/30/2009 9/29/2011. Role: Co-investigator
R01HL115295-01 Yale University/NHLBI 2015-2016 Project Title: Risk Stratification in Older Persons with Acute Myocardial Infarction (SILVER-AMI) Project period: 8/12/2012 - 5/31/2016; Role: Site P.I. Rhode Island Hospital
EFFICACY. Cogentus Pharmaceuticals, Inc. 6/08-1/09. A Randomized, Double blind, Double-Dummy, parallel Group, Phase 3 Efficacy and Safety Study CGT-2168 Compared to Clopidogrel to Reduce Upper Gastrointestinal Events Including Bleeding and Symptomatic Ulcer Disease. Role: P.I. Rhode Island Hospital. Study Terminated early by company for financial reasons
GRAVITAS. Synteract/Accumetrics. 7/08-2010. Gauging Responsiveness with a VerifyNow Assay-Impact on Thrombosis and Safety. Role: P.I. Rhode Island Hospital
DAPT. HCRI. 2009-2015. Dual anti-platelet therapy trial. Designed to examine whether 30 months of dual antiplatelet therapy is superior to 12 months in patients undergoing coronary intervention with stents. Role: P.I. Rhode Island Hospital
SAFE-PCI. Duke Clinical Research Institute. 12/2011-12/2013. Study of Access Site for Enhancement of PCI for Women. To compare the efficacy and feasibility of the transradial approach to percutaneous coronary intervention in women compared with the transfemoral approach in urgent or elective cardiac catheterization to evaluate ischemic symptoms. Role: P.I. Rhode Island Hospital
BOSS. MD Scientific, LLC. 2011-2014. Evaluation of Sodium Bicarbonate to Reduce Contrast-Induced Chronic Kidney Injury in Subjects with Advanced Chronic Kidney Disease (CKD) who are Undergoing Angiography. Role: P.I. Rhode Island Hospital
RIVER-PCI. Gilead. 2012-2015. RCT of ranolazine versus placebo in patients with chronic stable angina undergoing PCI with incomplete revascularization. Role: P.I. Rhode Island Hospital
RenalGuard. PLC Medical Systems, Inc. 2/2012-2017. A Study to Evaluate RenalGuard System Safety & Efficacy When Compared with Standard Care in the Prevention of Contrast Induced Nephropathy in the Setting of a Catherization laboratory. Role: P.I. Rhode Island Hospital
ABSORB. Abbott Cardiovascular systems Inc. 5/22/2013-ongoing. ABSORB Randomized Controlled Trial: A Clinical Evaluation Of Absort BVS, the Everolimus Eluting Biosorbable Vascular Scaffold in the Treatment of Subjects with De Novo Native Coronary Artery Lesions (protocol 10-392) Role: P.I. Rhode Island Hospital
Preservation. Ikaria, Inc./Duke Clinical Research Center 6/2013-2016. Phase II multicenter, randomized, double blind, placebo-controlled trial to evaluate the effects of IK-5001 for the prevention of ventricular remodeling and congestive heart failure after acute ST segment elevation myocardial infarction (STEMI). Role: P.I. Rhode Island Hospital
Regulate. Regado Biosciences. 3/2014-3/2015. A Randomized, Open-Label, Multi-Center, Active-Controlled, Parallel Group Study to Determine the Efficacy and Safety of the REG1 Anticoagulation System Compared to Bivalirudin in Patients Undergoing Percutaneous Coronary Intervention. Role: P.I. Rhode Island Hospital
PORTRAIT. St. Luke's Hospital/PCORI 3/1/2014-2/28/17.Patient-Centered Outcomes Related to Treatment Practices in Peripheral Arterial Disease: Investigating Trajectories (PORTRAIT Registry): Phase II. Role: P.I. Rhode Island Hospital
TAILOR PCI. Mayo Clinic Rochester 12/2014-ongoing. Prospective, randomized trial testing the hypothesis that after PCI, ticagrelor 90 mg bid is superior to clopidogrel 75 mg qd in reducing a composite endpoint of major adverse cardiovascular events in CYP2C19 reduced function allele patients. Role: P.I. Rhode Island Hospital
THEMIS. AstraZeneca/ICN 10/30/2014-ongoing. A Multinational, Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate the Effect of Ticagrelor 90mg twice Daily on the Incidence of Cardiovascular Death, Myocardial Infraction or Stroke in patients withType 2 Diabetes Mellitus (D513BC00001). Role: P.I. Rhode Island Hospital
BioNIR:RIH. Medinol Ltd. 6/24/2015-ongoing. BioNIR Ridaforolimus Eluting Coronary Stent System (BioNIR) In Coronary Stenosis Trial A multicenter, single blind, trial of BioNIR compared to Resolute. Role: P.I. Rhode Island Hospital
AUGUSTUS. Bristol-Myers Squibb, Inc 3/7/2016-ongoing. An Open-label, 2 x 2 Factorial, Randomized Controlled, Clinical Trial to Evaluate the Safety of Apixaban vs. Vitamin K Antagonist and Aspirin vs. Aspirin Placebo in Patients with Atrial Fibrillation and Acute Coronary Syndrome. Role: P.I. Rhode Island Hospital
Leaders Free II. Biosensors Research USA Inc. 5/2/2017-ongoing. A prospective study of the BiofreedomTM Biolimus A9TM drug coated stent in patients at high risk for bleeding. Role: P.I. Rhode Island Hospital
Xience Short DAPT. Abbott Vascular Inc. 12/20/2017-ongoing. A prospective, multicenter, single-arm study designed to assess the safety of 3-month DAPT in subjects at high risk for bleeding undergoing PCI with any approved XIENCE family of Stent Systems. Role: P.I. Rhode Island Hospital
PIONEER III. Sinomed. 7/2018-ongoing. A prospective, global, multi-center, randomized 2:1, single blind study to compare the safety and efficacy of the BuMA Supreme biodegradable coronary stent in patients with up to 3 coronary lesions to everolimus durable polymer stents.
AEGIS-II. CSL Behring, LLC. 11/27/2018- ongoing. A Phase 3, Multicenter, Double-Blind, Randomized, Placebo-Controlled, Parallel- Group Study to Investigate the Efficacy and Saftey of CSL112 in Subjects with Acute Coronary Syndrome. Role: P.I. Rhode Island Hospital
| Year | Degree | Institution |
|---|---|---|
| 1995 | MD | University of Chicago |
| 1991 | BA | Boston University |
Dean's Excellence in Teaching Award, Brown University, 2018
Frank Hildner Elite Reviewer, Catheterization Cardiovascular Interventions, 2018
RI Monthly Voted Top Doctor in Cardiology 2016
Frank Hildner Elite Reviewer, Catheterization and Cardiovascular Interventions, 2015
Awarded Master of Arts ad eundem, Brown University 2015
Raymond Riley MD Teaching Award, Cardiovascular Institute, Brown Medical School, 2014
Recognition of exemplary teaching BIO3662 IMS III: Cardiovascular, Brown Medical School, 2014
Certificate of Excellence in Reviewing, American Journal of Cardiology, 2013
Elite Reviewer for the Journal of American College of Cardiology Journals, 2013
Society for Cardiovascular Angiography and Interventions Emerging Leader Mentorship Program, National award, chosen as one of 10 physicians for a 2 year mentorship program to develop leaders in interventional cardiology, 2011-13
Recognition for exemplary teaching in BIO3662 IMS III: Cardiology, Brown Medical School, 2009
Cardiovascular Research Technologies Young Leadership Award, 2009
| Professor of Medicine, Teaching Scholar Track. Brown Medical School, 2019-2023 |
